Here we demonstrate quantitative ultra-short time-to-echo contrast-enhanced magnetic resonance imaging (qUTE-CE MRI) technique, which employs FDA-approved ferumoxytol as a positive-contrast agent to delineate nanoparticle accumulation in tumors.
This abstract and the presentation materials are available to members only; a login is required.